BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 1999
View Archived Issues
Immunomedics updates cancer therapeutics program following restructuring
Read More
Potential C. albicans vaccine tested in mice
Read More
Recombinant immunotoxin for hematological malignancies from NCI evaluated in phase I
Read More
Xoma and Genentech extend hu1124 agreement; present preliminary results from psoriasis trial
Read More
Structural Bioinformatics awarded SBIR grant for HER2 antagonists
Read More
New frontiers in gene therapy: treatment of erectile dysfunction
Read More
Further phase I data presented for bizelesin at AACR meeting
Read More
New compound for BPH in active preclinical development at Merck & Co. and Synaptic
Read More
BNP-7787 protects against taxane- and platinum-associated neurotoxicity
Read More
News from FASEB: novel botanical product for treatment of Alzheimer's disease
Read More
SBR-170: a new bioreductive alkylating agent selected for further evaluation
Read More
Avant Immunotherapeutics' CETP vaccine is effective in rabbit models of atherosclerosis
Read More
New, second-generation HIV fusion inhibitor from Trimeris to be evaluated clinically
Read More
First CpG DNA-based immunotherapeutic enters human trials
Read More
News from FASEB: YM-905 is a bladder-specific M3 receptor antagonist
Read More
Nonpeptide compounds derived from IL-1beta with peripheral analgesic activity
Read More
Novel antiepileptic drug from D-Pharm cleared for preliminary human trials
Read More
Preclinical study supports antinociceptive efficacy of ET-A antagonist
Read More
Preparation, activity, compositions and use of CCR3 receptor antagonists described by Roche
Read More
Akzo Nobel reports new agents for dysentery
Read More
Eisai research team discovers novel HIV-1 Tat antagonist
Read More
Bioglan and Allergan form psoriasis therapy partnership
Read More
FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer
Read More
New inhibitors of VCAM-1 binding to its receptor patented by Roche
Read More
Potent and long-lasting GnRH antagonist presented by Ferring
Read More
Potent and selective 5-HT1B/5-HT1D receptor agonists in the pipeline at Pierre Fabre
Read More
AACR news: squalamine evaluated for activity in prostate and lung cancer models
Read More
Health Canada grants priority review status for rofecoxib
Read More
